PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Eldepryl, Emsam, Otrasel, Zelapar

What is Selegiline? Selegiline is a Monoamine Oxidase (MAO) inhibitor. It is an antidepressant and anti-Parkinson's agent. When used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy by slowing the breakdown of levodopa. The transdermal product is used to treat depression.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

162 patients in the community are taking or have taken Selegiline.

Reason # Patients Percentage of patients
Treat Parkinson's 112 69%
Treat my mood condition(s) 8 4%
Stiffness/spasticity 7 4%
Other 6 3%
disease-related symptoms 4 2%
General health 2 1%
Hand tremor 1 <1%
Slowness 1 <1%
Excessive daytime sleepiness (somnolence) 1 <1%
Depression 1 <1%
Dry mouth (xerostomia) 1 <1%
Fatigue 1 <1%
Support another treatment 1 <1%

Dosages

Based on the patients currently taking Selegiline.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 mg none 0.1 mg day 0.5 mg day 1.25 mg day 1.5 mg day 1.5 day 2.25 mg day 2.5 mg day 3 mg day 5 mg day 5 mg none 6 mg day 10 mg day 12 mg day 15 mg day 20 mg day 40 mg day 125 mg day
  9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 13 Number of Patients: 13 1 Number of Patients: 1 17 Number of Patients: 17 1 Number of Patients: 1 1 Number of Patients: 1 43 Number of Patients: 43 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Selegiline or how long patients were taking Selegiline before stopping.

Currently taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
5
7
10
20
23

Stopped taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
13
2
5
4
7
16
Why Patients Stopped Taking Selegiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 14 29% Did not seem to work: 29%
Side effects too severe 14 29% Side effects too severe: 29%
Doctor's advice 11 23% Doctor's advice: 23%
Other 10 21% Other: 21%
Personal research 7 15% Personal research: 15%
Expense 4 8% Expense: 8%
Not indicated 2 4% Not indicated: 4%
Course of treatment ended 1 2% Course of treatment ended: 2%

Patient Reported Evaluations

Results from 15 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 33% 3
Moderate 22% 2
Slight 22% 2
Can't tell 22% 2

Treat Parkinson's

Side-effects (as an overall problem)

Severe 20% 3
Moderate 7% 1
Mild 13% 2
None 60% 9

Top reported side-effects include: trouble falling asleep, tiredness, Psychosis

Summary results are based on 15 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 15)

  • EfficacyCan't tell
  • Side-effectsNone
  • Treat Parkinson's

  • EfficacyModerate
  • Side-effectsNone
  • Depression
Advice/Tips
stick with it

See all evaluation results for Selegiline



Back to top